title: The serum response element can mediate induction of c-fos by growth hormone.
abstract: The c-fos protooncogene is transcriptionally activated by a wide variety of agents including serum, growth factors, and phorbol esters. This induction is rapid and transient and is mediated through a number of identified promoter elements. Growth hormone (GH) is also known to induce transcription of c-fos in a variety of cell types including NIH 3T3 fibroblasts and 3T3-F442A preadipocytes. To identify DNA sequences in the c-fos gene regulated by GH, this study sought to determine whether induction of c-fos by GH involves previously identified c-fos promoter elements. A plasmid containing a growth factor-sensitive fragment of the upstream region of the c-fos promoter from -361 to -264 bp was tested for GH sensitivity. The fragment was cloned upstream of a human c-fos reporter [designated FOS by Human Gene Mapping 11 (1991)], which included basal promoter elements. In transiently transfected mouse NIH 3T3 fibroblasts, the promoter fragment conferred GH sensitivity on the human c-fos reporter. To identify a specific GH-sensitive DNA sequence in this promoter, a serum response element (SRE)-reporter plasmid was tested and found to be stimulated by GH. GH was effective in inducing expression through the SRE over a range of physiological GH concentrations. Since GH was recently found to synergize with serum factors in inducing c-fos transcription, the effect of GH and serum on SRE function was examined for insight into the mechanism for such synergism. The combined effect of GH and serum to induce reporter expression through the SRE was greater than the added effects of GH and serum, indicating that the synergism between GH and serum in inducing c-fos involves the SRE sequence. These studies identify the SRE as one specific DNA sequence in the c-fos promoter functionally regulated by GH. It is notable that GH is effective at physiological concentrations. Furthermore, synergism in c-fos induction between GH and serum factors is evident through the SRE.
authors.affiliation: Department of Physiology, University of Michigan, Ann Arbor 48109.
authors.forename: D J
authors.initials: DJ
authors.lastname: Meyer
authors.forename: E W
authors.initials: EW
authors.lastname: Stephenson
authors.forename: L
authors.initials: L
authors.lastname: Johnson
authors.forename: B H
authors.initials: BH
authors.lastname: Cochran
authors.forename: J
authors.initials: J
authors.lastname: Schwartz
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001483:Base Sequence; D001790:Blood Physiological Phenomena; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D013006:Growth Hormone / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic / Q000235:genetics*; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis* / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects*
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D013006:Growth Hormone